Stock Yards Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Sell
68,196
-3,041
-4% -$81K 0.06% 163
2025
Q4
$1.77M Sell
71,237
-14,436
-17% -$364K 0.05% 173
2025
Q3
$2.18M Sell
85,673
-7,381
-8% -$182K 0.07% 150
2025
Q2
$2.26M Buy
93,054
+551
+0.6% +$12.8K 0.08% 135
2025
Q1
$2.34M Sell
92,503
-9,878
-10% -$258K 0.08% 127
2024
Q4
$2.72M Sell
102,381
-12,171
-11% -$330K 0.09% 127
2024
Q3
$3.32M Sell
114,552
-7,636
-6% -$223K 0.11% 124
2024
Q2
$3.42M Sell
122,188
-14,273
-10% -$393K 0.11% 119
2024
Q1
$3.79M Sell
136,461
-20,954
-13% -$581K 0.13% 119
2023
Q4
$4.53M Sell
157,415
-45,973
-23% -$1.39M 0.16% 100
2023
Q3
$6.75M Sell
203,388
-23,331
-10% -$825K 0.26% 76
2023
Q2
$8.32M Sell
226,719
-14,933
-6% -$581K 0.3% 72
2023
Q1
$9.86M Buy
241,652
+26,238
+12% +$1.13M 0.38% 64
2022
Q4
$11M Buy
215,414
+3,087
+1% +$148K 0.43% 61
2022
Q3
$9.29M Buy
212,327
+1,137
+0.5% +$55.3K 0.4% 64
2022
Q2
$11.1M Buy
211,190
+82,670
+64% +$4.21M 0.46% 60
2022
Q1
$6.65M Sell
128,520
-616
-0.5% -$32K 0.37% 62
2021
Q4
$7.63M Buy
129,136
+42,114
+48% +$2.09M 0.4% 58
2021
Q3
$3.74M Buy
87,022
+823
+1% +$36.5K 0.24% 66
2021
Q2
$3.38M Sell
86,199
-5,975
-6% -$232K 0.21% 74
2021
Q1
$3.34M Sell
92,174
-4,247
-4% -$151K 0.23% 72
2020
Q4
$3.55M Sell
96,421
-2,535
-3% -$93K 0.26% 64
2020
Q3
$3.45M Buy
98,956
+5,788
+6% +$203K 0.29% 61
2020
Q2
$2.89M Buy
93,168
+1,534
+2% +$52.1K 0.26% 66
2020
Q1
$2.84M Sell
91,634
-852
-0.9% -$29K 0.3% 62
2019
Q4
$3.44M Sell
92,486
-1,582
-2% -$56.4K 0.29% 66
2019
Q3
$3.21M Sell
94,068
-1,955
-2% -$71.1K 0.29% 67
2019
Q2
$3.95M Buy
96,023
+5,497
+6% +$218K 0.37% 61
2019
Q1
$3.65M Buy
90,526
+2,770
+3% +$111K 0.36% 63
2018
Q4
$3.63M Sell
87,756
-1,456
-2% -$60.4K 0.4% 61
2018
Q3
$3.73M Buy
89,212
+636
+0.7% +$24.5K 0.38% 60
2018
Q2
$3.05M Sell
88,576
-37,507
-30% -$1.28M 0.34% 64
2018
Q1
$4.25M Buy
126,083
+1,716
+1% +$59K 0.47% 55
2017
Q4
$4.27M Sell
124,367
-1,878
-1% -$64K 0.47% 54
2017
Q3
$4.28M Sell
126,245
-4,240
-3% -$136K 0.5% 54
2017
Q2
$4.16M Buy
130,485
+877
+0.7% +$27.7K 0.5% 56
2017
Q1
$4.21M Sell
129,608
-32,713
-20% -$1.03M 0.53% 55
2016
Q4
$5M Sell
162,321
-2,375
-1% -$72.5K 0.66% 52
2016
Q3
$5.29M Sell
164,696
-3,845
-2% -$129K 0.72% 51
2016
Q2
$5.63M Buy
168,541
+1,350
+0.8% +$43.1K 0.75% 50
2016
Q1
$4.7M Sell
167,191
-11,467
-6% -$328K 0.67% 54
2015
Q4
$5.47M Sell
178,658
-1,545
-0.9% -$48.6K 0.76% 46
2015
Q3
$5.37M Buy
180,203
+1,392
+0.8% +$44.6K 0.82% 47
2015
Q2
$5.69M Sell
178,811
-4,524
-2% -$147K 0.81% 48
2015
Q1
$6.05M Sell
183,335
-18,667
-9% -$593K 0.86% 45
2014
Q4
$5.97M Buy
202,002
+20,087
+11% +$576K 0.85% 46
2014
Q3
$5.1M Sell
181,915
-16,991
-9% -$477K 0.77% 52
2014
Q2
$5.6M Sell
198,906
-3,029
-1% -$86.3K 0.79% 50
2014
Q1
$6.15M Buy
201,935
+5,446
+3% +$162K 0.89% 48
2013
Q4
$5.71M Sell
196,489
-1,830
-0.9% -$53.3K 0.85% 50
2013
Q3
$5.4M Sell
198,319
-3,147
-2% -$85.6K 0.86% 49
2013
Q2
$5.36M Buy
+201,466
New +$5.57M 0.59% 47

Other funds holding PFE

Stock Yards Bank & Trust's PFE Position: Q1 2026 in Review

Stock Yards Bank & Trust reduced its Pfizer (PFE) stake by 4.3% in Q1 2026, selling an estimated $81K and leaving 68,196 shares worth $1.91M. The position accounts for 0.06% of the portfolio, ranked #163.

Stock Yards Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.1M in Q2 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Stock Yards Bank & Trust held 68,196 shares of Pfizer worth $1.91M as of Q1 2026.
  • Stock Yards Bank & Trust sold 3,041 Pfizer shares in Q1 2026, an estimated $81K.
  • Pfizer made up 0.06% of Stock Yards Bank & Trust's portfolio in Q1 2026, its #163 holding.
  • Stock Yards Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Stock Yards Bank & Trust's Pfizer position peaked at $11.1M in Q2 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Stock Yards Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.